Study guide
16.3 Electronic Data Capture (EDC) Systems
Certified Clinical Research Coordinator CCRC
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Scientific Concepts and Research Design
1.1 Protocol Elements 1.2 Study Design and Objectives 1.3 Study Endpoints and Biostatistics
2 Chapter 2: Ethical Principles and Guidelines
2.1 Ethical Principles (Declaration of Helsinki, Belmont Report) 2.2 Informed Consent Process and Documentation 2.3 Vulnerable Populations and Assent
3 Chapter 3: IRB/IEC Oversight and Participant Safety
3.1 IRB/IEC Functions and Oversight 3.2 Adverse Event Classification and Reporting 3.3 Safety Monitoring and Safety Reporting
4 Chapter 4: Participant Rights and Ethics
4.1 Participant Rights and Confidentiality (HIPAA/GDPR) 4.2 Conflicts of Interest 4.3 Ethical Scenarios in Clinical Trials
5 Chapter 5: Product Development and Regulatory Framework
5.1 Drug and Device Development Phases 5.2 U.S. and International Regulatory Frameworks 5.3 Investigational Product Investigator's Brochure (IB)
6 Chapter 6: Investigational Product Accountability
6.1 Investigational Product Labeling and Storage 6.2 Investigational Product Receipt, Dispensing, and Accountability 6.3 Investigational Product Return and Destruction
7 Chapter 7: Regulatory Submissions and Actions
7.1 Regulatory Submissions (IND, NDA, IDE, PMA) 7.2 Regulatory Actions and Compliance 7.3 Pharmacokinetics and Pharmacodynamics in Product Development
8 Chapter 8: Clinical Trial Operations and GCP Principles
8.1 Introduction to ICH E6 GCP Principles (including R3 updates) 8.2 Investigator Responsibilities under GCP 8.3 Sponsor Responsibilities and Oversight
9 Chapter 9: Essential Documents and Site Qualification
9.1 Essential Documents (Pre-study, During, Post-study) 9.2 Site Selection and Qualification 9.3 Quality Management and Standard Operating Procedures (SOPs)
10 Chapter 10: Protocol Deviations and Amendments
10.1 Protocol Adherence and Compliance 10.2 Protocol Deviations and Violations 10.3 Protocol Amendments and Version Control
11 Chapter 11: Monitoring Visits and Audits
11.1 Monitoring Preparation and Visit Types 11.2 Monitoring Visits (SIV, IMV, COV) 11.3 Regulatory Inspections and Site Audits
12 Chapter 12: Study and Site Management - Startup
12.1 Site Startup Operations 12.2 Site Budget and Contract Management 12.3 Site Staffing, Training, and Documentation
13 Chapter 13: Enrollment and Recruitment
13.1 Enrollment Management and Strategies 13.2 Participant Recruitment and Retention 13.3 Participant Compensation and Ethics
14 Chapter 14: Daily Trial Coordination
14.1 Visit Scheduling and Logistics 14.2 Equipment Maintenance and Calibration 14.3 Specimen Handling and Shipping (IATA/dangerous goods)
15 Chapter 15: Quality Improvement and Site Closeout
15.1 Participant Safety Management 15.2 Quality Improvement and Site Audits Preparation 15.3 Study and Site Closeout Procedures
16 Chapter 16: Source Documentation and Case Report Forms
16.1 Source Documentation Standards (ALCOA-C) 16.2 Case Report Forms and eCRF Completion 16.3 Electronic Data Capture (EDC) Systems
17 Chapter 17: Data Management and Queries
17.1 Data Management Processes 17.2 Data Queries and Discrepancy Resolution 17.3 Data Correction and Audit Trails
18 Chapter 18: Data Privacy and Records Retention
18.1 Data Privacy and Confidentiality 18.2 Records Retention and Archiving 18.3 Compliance in Clinical Trial Informatics
16.3 Electronic Data Capture (EDC) Systems
Key Takeaways Explain This Topic AI
EDC systems are software platforms used to collect, clean, and manage trial data.
21 CFR Part 11 sets the rules for electronic records, requiring validation, audit trails, and secure electronic signatures.
Role-Based Access Control ensures that only authorized personnel can enter, view, or sign off on data based on their role.
Automated edit checks (like range and logical checks) improve data quality at the point of entry.
Database lock freezes the data to prevent further alterations prior to statistical analysis.
Last updated: October 2026
Electronic Data Capture (EDC) Systems
In contemporary clinical research, the transition from paper to digital has made Electronic Data Capture (EDC) systems the backbone of trial data management. An EDC system is a computerized system designed for the collection, cleaning, and management of clinical trial data in electronic format.
Commonly used EDC platforms include Medidata Rave, Oracle Clinical One, Veeva Vault CDMS, and REDCap. Understanding how these systems function, their regulatory requirements, and their interaction with other trial technologies is crucial for a Clinical Research Coordinator (CRC).
Regulatory Compliance: 21 CFR Part 11
In the United States, any electronic system used to collect data submitted to the FDA must comply with 21 CFR Part 11 . This regulation establishes the criteria under which the FDA considers electronic records and electronic signatures to be trustworthy, reliable, and equivalent to paper records and handwritten signatures.
Key requirements of 21 CFR Part 11 include:
Validation: The system must be validated to ensure accuracy, reliability, and consistent intended performance.
Audit Trails: The system must generate a secure, computer-generated, time-stamped audit trail that independently records the date and time of operator entries and actions that create, modify, or delete electronic records. The audit trail must not obscure previous entries.
Access Controls: System access must be strictly limited to authorized individuals. Passwords must expire periodically, and accounts lock after failed attempts.
Electronic Signatures: Electronic signatures must be uniquely linked to one individual, legally binding, and require components like a password and a unique PIN at the time of signing.
- Key Features of EDC Systems
- User Management and Role-Based Access Control
EDC systems employ Role-Based Access Control (RBAC) . A user's role dictates what they can see and do within the system.
CRC/Data Entry: Can enter data, modify data, and respond to queries.
Principal Investigator (PI): Can enter data, respond to queries, and apply electronic signatures to sign off on casebooks.
CRA (Monitor): Has "read-only" access. They can view data for Source Data Verification (SDV) and issue queries but cannot enter or change clinical data.
Data Manager: Can review data, issue complex queries, and lock the database.
CRCs must complete sponsor-mandated, system-specific training before being granted access. Usernames and passwords are strictly individual; sharing login credentials is a severe violation of 21 CFR Part 11 and GCP.
Edit Checks (Automated Logic)
EDC systems are programmed with edit checks —automated rules designed to catch errors at the point of data entry.
Range Checks: If a CRC enters a subject's heart rate as 750 bpm instead of 75 bpm, the system immediately flags the value as out of range and prevents saving or generates an immediate query.
Logical Checks: If a subject is recorded as male at the screening visit, the EDC will automatically disable or hide forms related to pregnancy tests or gynecological exams.
Date Checks: The system ensures that the date of a Visit 2 cannot be prior to the date of Visit 1.
Edit checks drastically reduce the manual review required by Data Managers and CRAs, leading to cleaner data in real-time.
The Query Management Lifecycle
The query lifecycle in an EDC system is a structured process for resolving data discrepancies:
Query Generation: A query is opened (either automatically by an edit check or manually by a CRA/Data Manager).
Site Response: The CRC reviews the query, checks the source document, corrects the data if necessary, and provides a text response.
Review: The CRA or Data Manager reviews the CRC's response and the corrected data.
Closure: If the response is satisfactory, the query is closed. If not, it is re-issued for further clarification.
System Integrations
Modern EDC systems rarely operate in isolation. They are often integrated with other clinical technologies to streamline data collection and reduce transcription errors.
Interactive Voice/Web Response Systems (IVRS/IWRS): Used for subject randomization and drug supply management. When a subject is randomized in the IRT (Interactive Response Technology), the data (e.g., Randomization Number, Treatment Arm) automatically populates into the EDC system.
Electronic Patient-Reported Outcomes (ePRO) / eCOA: Subjects complete diaries or questionnaires directly on a provided tablet or smartphone app. This data flows seamlessly into the EDC, functioning as eSource (electronic source data), eliminating the need for the CRC to transcribe paper diary entries.
Central Laboratories: Instead of CRCs manually typing lab results from a printout into the eCRF, the central lab transmits the data electronically via an API (Application Programming Interface) directly into the EDC system.
Database Lock
At the conclusion of a clinical trial (or at interim analysis points), the data undergoes final cleaning. All source data verification is complete, all queries are resolved and closed, and the Principal Investigator has electronically signed all required casebooks.
Once these criteria are met, the Data Management team performs a Database Lock .
Locking the database removes "write" access for all users.
No further changes can be made to the data, ensuring the integrity of the dataset before it is transferred to biostatisticians for final statistical analysis.
If a critical error is discovered post-lock, a highly controlled "database unlock" process must be initiated, documented, and approved by senior sponsor management.
Advantages and Challenges
Advantages:
Faster data availability for safety monitoring.
Built-in edit checks improve data quality at the source.
Immediate query visibility speeds up resolution.
Reduced physical storage requirements compared to paper CRFs.
Challenges:
Heavy reliance on site internet connectivity.
Requirement for continuous, documented training for site staff.
Managing multiple logins for CRCs who work on various trials using different EDC platforms.